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Abstract
Background: Purely epistatic multi-locus interactions cannot generally be detected via single-
locus analysis in case-control studies of complex diseases. Recently, many two-locus and multi-
locus analysis techniques have been shown to be promising for the epistasis detection. However,
exhaustive multi-locus analysis requires prohibitively large computational efforts when problems
involve large-scale or genome-wide data. Furthermore, there is no explicit proof that a
combination of multiple two-locus analyses can lead to the correct identification of multi-locus
interactions.
Results: The proposed 2LOmb algorithm performs an omnibus permutation test on ensembles of
two-locus analyses. The algorithm consists of four main steps: two-locus analysis, a permutation
test, global p-value determination and a progressive search for the best ensemble. 2LOmb is
benchmarked against an exhaustive two-locus analysis technique, a set association approach, a
correlation-based feature selection (CFS) technique and a tuned ReliefF (TuRF) technique. The
simulation results indicate that 2LOmb produces a low false-positive error. Moreover, 2LOmb has
the best performance in terms of an ability to identify all causative single nucleotide polymorphisms
(SNPs) and a low number of output SNPs in purely epistatic two-, three- and four-locus interaction
problems. The interaction models constructed from the 2LOmb outputs via a multifactor
dimensionality reduction (MDR) method are also included for the confirmation of epistasis
detection. 2LOmb is subsequently applied to a type 2 diabetes mellitus (T2D) data set, which is
obtained as a part of the UK genome-wide genetic epidemiology study by the Wellcome Trust Case
Control Consortium (WTCCC). After primarily screening for SNPs that locate within or near 372
candidate genes and exhibit no marginal single-locus effects, the T2D data set is reduced to 7,065
SNPs from 370 genes. The 2LOmb search in the reduced T2D data reveals that four intronic SNPs
in PGM1 (phosphoglucomutase 1), two intronic SNPs in LMX1A (LIM homeobox transcription
factor 1, alpha), two intronic SNPs in PARK2 (Parkinson disease (autosomal recessive, juvenile) 2,
parkin) and three intronic SNPs in GYS2 (glycogen synthase 2 (liver)) are associated with the
disease. The 2LOmb result suggests that there is no interaction between each pair of the identified
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genes that can be described by purely epistatic two-locus interaction models. Moreover, there are
no interactions between these four genes that can be described by purely epistatic multi-locus
interaction models with marginal two-locus effects. The findings provide an alternative explanation
for the aetiology of T2D in a UK population.
Conclusion: An omnibus permutation test on ensembles of two-locus analyses can detect purely
epistatic multi-locus interactions with marginal two-locus effects. The study also reveals that SNPs
from large-scale or genome-wide case-control data which are discarded after single-locus analysis
detects no association can still be useful for genetic epidemiology studies.
Background
Complex diseases cannot generally be explained by Men-
delian inheritance [1] because they are influenced by
gene-gene and gene-environment interactions. Many
common diseases such as asthma, cancer, diabetes, hyper-
tension and obesity are widely accepted and acknowl-
edged to be results of complex interactions between
multiple genetic factors [2]. Attempts to identify factors
that could be the causes of complex diseases have led to
many genome-wide association studies [3,4]. Raw results
from these attempts produce a large amount of single
nucleotide polymorphism (SNP) data from every individ-
ual participating in the trials.
For genetic epidemiologists, data sets from genome-wide
association studies present many challenges, particularly
the correct identification of SNPs that associate with the
disease of interest from all available SNPs [5]. This chal-
lenge can be treated as a pattern recognition problem
which aims to identify an attribute or SNP set that can
lead to the correct classification of recruited samples. Hei-
dema et al. [5] and Motsinger et al. [6] have reviewed and
identified many machine learning techniques that are
suitable to the task. Among many strategies and tech-
niques, the protocol that appears to be most promising for
genome-wide association studies involves two main steps:
SNP set reduction and classification model construction
[7]. From a machine learning viewpoint, attribute selec-
tion techniques can be divided into three main categories:
filter, wrapper and embedded approaches [8]. In a filter
approach, a measure or an index is used to determine the
correlation between attributes and classes, e.g. affected
and unaffected status in a case-control study. Attributes
that are deemed to be important for the classification
according to the measure are then selected. The filter
approach includes χ2 and odds ratio tests [9,10], omnibus
permutation tests [11-13], a correlation-based feature
selection technique [14], a ReliefF technique [15] and a
tuned ReliefF technique [16]. In a wrapper approach, the
significance of an attribute subset is evaluated from the
classification performance by a classifier. The capability of
the wrapper approach to identify significant attributes
thus depends on the chosen classifier and the search algo-
rithm for the identification of the best attribute subset.
Combinatorial [17] and restricted partitioning methods
[18], a multifactor dimensionality reduction method [19-
25] and a polymorphism interaction analysis technique
[26] are examples of the wrapper approach. An embedded
approach concentrates on informative attributes during
the construction of a classification model. Examples of the
embedded approach include a genetic algorithm with
Boolean algebra [27], genetic programming based deci-
sion trees [28,29], random forests [30-32] and evolution-
ary neural networks [33,34]. Based on this categorisation,
classification models are not direct outputs from filter-
based techniques. On the other hand, classification mod-
els are readily prepared as outputs from the wrapper and
embedded approaches. In other words, the last two
approaches can also be regarded as classification model
construction techniques.
The success of the two-step pattern recognition approach
relies heavily on the attribute selection step [14]. In case-
control studies, epistatic effects play a vital role in estab-
lishing the difficulty level of SNP screening problems
[35,36]. Epistasis in the simplest form can be represented
by disease models that require genotype inputs from two
interacting SNPs [37,38]. Many attempts have been made
to produce consistent definitions and categorisation of
different types of epistasis models [2,35,39-41]. Accord-
ing to Musani et al. [2], a pure epistasis model [42] is dif-
ficult because each SNP exhibits no marginal single-locus
effect in the model. As a result, it is impossible to detect
the pure epistasis by univariate statistical tests. Examples
of complex diseases that case-control studies have uncov-
ered putatively pure epistasis include type 2 diabetes mel-
litus (T2D) [43-46] and metabolic syndrome [47]. Due to
the difficulty of screening for each SNP independently, it
is suggested that attention should be focused on the anal-
ysis of differences between two-locus genotype distribu-
tion within case and control groups [40] and multi-locus
Bayesian statistical analysis [48,49].
A number of SNP screening and association detection
techniques have adopted the two-locus genotype moni-
toring strategy as their core engines [40,50-52]. The search
for interactions can be carried out via either exhaustive
analysis [52] or the analysis that can be divided into twoBMC Bioinformatics 2009, 10:294 http://www.biomedcentral.com/1471-2105/10/294
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stages, incorporating single-locus analysis for the pre-
screening purpose [40,50,51]. In the two-stage mode, at
least one SNP that involves in the construction of two-
locus genotype unit must be a strong candidate for the
association explanation, usually verified through univari-
ate statistical tests. Each mode of the two-locus analysis
possesses different strengths and weaknesses. The exhaus-
tive analysis has a full capability of detecting pure epistasis
but requires larger computational efforts [52]. In contrast,
the two-stage analysis is more practical for large-scale data
but with some risk of missing possible pure epistasis [50].
More practical usage of both two-locus analysis modes in
real case-control studies is required before the feasibility
issue can be fully addressed.
Many genetic association studies reveal that various com-
plex diseases are results of putative multi-locus interac-
tions [11,46,53]. With the constraints on a computational
capability, exhaustive multi-locus analysis in large-scale
or genome-wide association studies would be infeasible
[52]. On the other hand, single-locus analysis would be
unsuitable for the detection of pure epistasis. One possi-
ble approach that provides a trade-off between a compu-
tational limitation and an epistasis detection capability is
to capture a multi-locus interaction by combining multi-
ple results from two-locus analysis. To achieve this, it is
necessary to prove that once a multi-locus interaction
model is broken down into a combination of two-locus
models, all or some of these models remain detectable
through two-locus analysis. Although it is hinted in an
early work on two-locus analysis [52] that the proposed
approach is plausible, explicit experimentation and test-
ing has never been conducted.
In this article, the feasibility of employing an ensemble of
two-locus analyses for the multi-locus interaction deter-
mination is demonstrated. Specifically, the significance of
the two-locus analysis ensemble is assessed by an omni-
bus permutation test [54]. The proposed method is
inspired by a set association approach [11], in which a
limited number of sets that contain different numbers of
SNPs are explored for possible association. These SNP sets
are crucial in the global p-value calculation of the selected
set via a permutation test and thus the decision to accept
or reject the null hypothesis of no association. In other
words, SNP set exploration and selection is required to
assess the significance of the identified association. This
means that the set association approach is equally inter-
ested in both SNP set selection and testing for significant
association. The primary function of the proposed
method is to detect possible association and assess its sig-
nificance through the exploration of different ensembles
of two-locus analyses. Hence, the proposed method is
also equally interested in both ensemble selection and
testing for significant association.
The proposed method is benchmarked against a simple
exhaustive two-locus analysis technique, the set associa-
tion approach [11], the correlation-based feature selection
technique [14] and the tuned ReliefF technique [16].
These filter-based attribute selection techniques are suita-
ble for the benchmark trial since they are capable of
detecting association. The case-control classification mod-
els constructed from screened SNPs via a multifactor
dimensionality reduction method [19] are also provided.
Results and discussion
Algorithm
The proposed algorithm performs an omnibus permuta-
tion test on ensembles of two-locus analyses and is
referred to as a 2LOmb technique. The algorithm consists
of four steps as illustrated in Figure 1 and can be described
as follows.
Two-locus analysis
Consider a case-control genetic association study with nm
SNPs, for each pair of SNPs, a 2 × 9 contingency table with
rows for disease status and columns for genotype configu-
rations is created. A χ2 test statistic and the corresponding
p-value can subsequently be computed. With the total of
nm SNPs, there are   = nm!/((nm - 2)!2!) possible SNP
pairs. As a result, the p-value from each two-locus analysis
must be adjusted by a Bonferroni correction. The Bonfer-
roni-corrected  p-value from each analysis is the lower
value between   × the uncorrected p-value and one.
Permutation test
The p-value   for the null hypothesis   that ensemble
e--an ensemble of two-locus analyses of interest--is not
associated with the disease can be evaluated by a permu-
tation test. To achieve this, a scalar statistic is first com-
puted from a function that combines the Bonferroni-
corrected χ2's p-values of individual two-locus tests. A suit-
able combining function must (a) be non-increasing in
each p-value, (b) attain its maximum value when any p-
value equals to zero and (c) have a finite critical value that
is less than its maximum for any significant level greater
than zero [54]. In this study, a Fisher's combining func-
tion (-2∑i log(pi)) is selected [55]. The p-value for the
ensemble of two-locus analyses is assessed via a permuta-
tion simulation. In each permutation replicate, samples
are constructed such that the case/control status of each
sample is randomly permuted while the total numbers of
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Outline of 2LOmb Figure 1
Outline of 2LOmb. In this example, the algorithm takes a balanced case-control data set that consists of 400 samples and 
1,000 SNPs. Each genotype is represented by an integer: 0 denotes a homozygous wild-type genotype, 1 denotes a hetero-
zygous genotype and 2 denotes a homozygous variant or homozygous mutant genotype. A χ2 contingency table is then con-
structed for each pair of SNPs in two-locus analysis. This results in the total of   = 499,500 two-locus analyses. Thus, 
the Bonferroni-corrected χ2's p-value for each two-locus analysis is the lower value between 499,500 × its uncorrected p-value 
and one. In one ensemble, Bonferroni-corrected χ2's p-values from multiple two-locus analyses are combined together via a 
Fisher's combining function, which in turn provides a Fisher's test statistic result. The raw p-value for the ensemble is obtained 
through a permutation test, which is composed of 10,000 randomised permutation replicates. Since multiple ensembles may be 
tried during the identification of the best association explanation, a global p-value is calculated to account for multiple hypoth-
esis testing. The global p-value is estimated through the same permutation test that gives the raw p-value for each ensemble. 
The progressive search for the best association explanation is carried out by incrementally adding a two-SNP unit to the cur-
rent best ensemble. The condition for search termination is based on both the raw p-value for the explored ensemble and the 
global p-value. In this example, the search is terminated after the fourth ensemble is explored due to an increase in the raw p-
value. Subsequently, the best SNP set for association explanation contains SNP1, SNP2 and SNP3 where the global p-value that 
accounts for testing of four hypotheses is p < 0.0001.
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case and control samples remain unchanged. A χ2 contin-
gency table with new entries and a Bonferroni-corrected p-
value for the two-locus analysis within each permutation
replicate are then obtained. This, in turn, leads to a new
Fisher's test statistic. Let   denote the value of Fisher's
test statistic obtained for the ith permutation replicate, 
is the fraction of permutation replicates with a test statistic
greater than or equal to the test statistic obtained from the
original case-control data ( ). In other words,
where t is the number of permutation replicates which is
set to 10,000 in this study and |·| denotes the size of a set.
Global p-value determination
There are many candidate ensembles of two-locus analy-
ses that can be explored. Let   be the glo-
bal null hypothesis that none of E explored ensembles of
two-locus analyses is associated with the disease, the test
of the global null hypothesis leads to the global p-value
and provides the genetic association explanation. In step
2, the p-value   for a fixed hypothesis   is a raw or
unadjusted p-value. To account for the correlation among
multiple hypotheses that have been tested during the
exploration through many candidate ensembles, the test-
ing result of the global null hypothesis depends on
. In other words, the global null hypothe-
sis is rejected if the minimum of the raw p-values is suffi-
ciently small. The distribution of   can again be
determined by a permutation simulation. However, a
nested simulation is unnecessary since the same set of per-
mutation replicates for the   determination can be
reused in the estimation of the empirical distribution of
[56]. This strategy has been successfully imple-
mented in a number of genetic association detection tech-
niques, including a set association approach [11] and a
haplotype interaction approach embedded in FAMHAP
[57,58]. The unadjusted p-value for the permutation rep-
licate i of each hypothesis e is thus given by
Let   be the minimum of unadjusted p-val-
ues over all explored ensembles of two-locus analyses in
the ith permutation replicate, the p-value for the global
null hypothesis H0 is defined by
Search for the best ensemble of two-locus analyses
A simple progressive search is used to identify the best
ensemble of two-locus analyses. The search begins by
locating the best two-SNP unit with the smallest Bonfer-
roni-corrected χ2's p-value from step 1. A permutation test
is then performed for this two-locus analysis, yielding
both raw and global p-values since only one hypothesis
has been explored. Next, the search attempts to combine
the existing best two-SNP unit with the two-SNP unit that
possesses the next smallest Bonferroni-corrected χ2's p-
value from step 1 and does not have a higher permutation
p-value than the first two-SNP unit. If this new ensemble
yields either a higher raw p-value or the same raw p-value
but a higher global p-value from a permutation test, the
search is terminated and the association is explained by
the previously identified two-locus analysis. Otherwise,
the best ensemble of two-locus analyses is updated and
the process of appending more two-SNP units to the
ensemble continues. The progressive search terminates
when deterioration in the raw or global p-value is
detected, or all possible two-locus analyses have been
included in the ensemble. It is recalled from step 3 that for
the best ensemble containing E  - 1 <  two-locus
analyses, its global p-value is obtained from the evalua-
tion of E hypotheses.
Validity of the algorithm
A permutation replicate in 2LOmb is constructed by ran-
domly assigning the case or control status to each sample
while maintaining the original proportion of case and
control samples. Once the construction of a permutation
replicate is finished, the assigned case and control labels
remain fixed to the samples. The pattern of case and con-
trol labels in each permutation replicate is thus constant
and unique. Therefore, the Bonferroni-corrected χ2's p-
values from any two-SNP units within a permutation rep-
licate are calculated from the same case-control data set.
Hence, the combining of these Bonferroni-corrected χ2's
p-values via a Fisher's combining function is attainable.
The calculation of Fisher's test statistics from all permuta-
tion replicates and the original data set leads to the raw or
unadjusted p-value   for the null hypothesis   of the
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ensemble e as given in equation 1. Since the same set of
permutation replicates is always used during the evalua-
tion of each ensemble, the raw p-values for the null
hypotheses from all ensembles can be directly compared
against one another. Furthermore, the global p-value cal-
culation is based on this set of permutation replicates.
This is possible because the unadjusted p-value for the per-
mutation replicate i of ensemble e or   can  be  calculated
in a similar manner to the raw p-value   as defined in
equation 2. The unadjusted p-values for the same permu-
tation replicate but different ensembles can also be
directly compared and the subsequent calculation of
 is attainable. With   and
, the p-value for the global null hypothesis
 that incorporates all E explored hypoth-
eses can be determined by equation 3. In summary, only
one set of permutation replicates is required for the calcu-
lation of both the raw p-value for the null hypothesis of
every ensemble and the global p-value. The p-values can
be compared in each step of 2LOmb. Consequently, the
selection of the best ensemble for association explanation
can be carried out via a p-value comparison.
Testing with simulated data
2LOmb is benchmarked against a simple exhaustive two-
locus analysis technique, a set association approach (SAA)
[11], a correlation-based feature selection (CFS) tech-
nique [14] and a tuned ReliefF (TuRF) technique [16] in a
simulation trial. The exhaustive two-locus analysis is sim-
ply the two-locus analysis procedure from the first step of
the 2LOmb algorithm. An interaction is declared if at least
one two-SNP unit with a Bonferroni-corrected χ2's p-value
below 0.05 is detected. The exhaustive two-locus analysis
reports all SNPs that meet this detection condition. The
simulation covers two main data categories: null data of
no significant genetic association and data with causative
SNPs which signify pure epistasis. The algorithm perform-
ance on the null data provides an indication for the false-
positive error. On the other hand, the algorithm perform-
ance on the data with causative SNPs indicates the detec-
tion capability. An efficient algorithm should produce an
output with a low number of SNPs and a high number of
correctly-identified causative SNPs when epistasis is
present. Similarly, it should also report that there are no
causative SNPs in the null data. These two measures on
the number of SNPs in the results are used as the perform-
ance indicators.
Each simulated data set contains 1,000, 2,000 or 4,000
SNPs in which either there are no causative SNPs or there
is pure epistasis, governed by two, three or four causative
SNPs. The allele frequencies of all causative SNPs are 0.5
while the minor allele frequencies of the remaining SNPs
are between 0.05 and 0.5. The data set consists of bal-
anced case-control samples of sizes 400, 800 or 1,600. All
SNPs in control samples are in Hardy-Weinberg equilib-
rium (HWE) [59]. The genotype distribution of causative
interacting SNPs follows the pure epistasis model by Cul-
verhouse et al. [42], leading to three interesting values of
heritability: 0.01, 0.025 and 0.05. Every SNP in each data
set exhibits no marginal single-locus effect (Bonferroni-
corrected χ2's p-value > 0.05). Twenty-five independent
data sets for each simulation setting are generated via a
genomeSIM package [60]. A paired t-test is suitable to
assess the significance of results since the same simulated
data sets are used during the algorithm benchmarking.
The results from the null data problem are summarised in
Figure 2 while the results from the two-, three-and four-
locus interaction problems are shown in Figures 3-4, 5-6
and 7-8, respectively. Clearly, 2LOmb significantly out-
performs other techniques in terms of the low number of
output SNPs, the high number of correctly-identified
causative SNPs or both in every interaction problem (a
paired t-test on 675 benchmark results yields a p-value <
0.05). On the other hand, both 2LOmb and SAA have the
lowest false-positive error when compared to other tech-
niques in the null data problem (a paired t-test on 225
benchmark results yields a p-value < 0.05). The statistical
power analysis also reveals that the benchmark trial with
25 independent data sets for each simulation setting is
sufficient for an accurate evaluation of the overall algo-
rithm performance (power > 0.95 for a Type I error rate of
0.05). These results can be further interpreted as follows.
The performance of many existing attribute selection tech-
niques for pattern recognition depends on the level of
attribute interactions. A number of techniques, including
CFS, appear to function well under a moderate level of
interactions. However, the performance of CFS appears to
be significantly reduced when the interaction level
becomes too high [14,61] because CFS favours an
attribute that is strongly correlated with the classification
outcome--disease status in this study--while at the same
time is not correlated with other attributes. Since the main
driving force behind epistasis is the interaction between
SNPs, which are themselves attributes, CFS would not
intuitively select all causative SNPs. Consequently, the
SNP set produced by CFS appears to contain only uncor-
related SNPs. Obviously, a SNP that is a part of the inter-
action model would occasionally be picked up by CFS but
CFS never successfully identifies all causative SNPs in any
interaction problems. In addition, CFS reports more erro-
neous SNPs than other techniques in the null data prob-
lem and all three interaction problems due to many SNPs
being uncorrelated.
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The benchmarking of attribute selection techniques by
Hall and Holmes [14] also reveals that ReliefF [15] is bet-
ter than CFS in problems with a high level of interactions.
Since ReliefF is essentially the core engine of TuRF, the
results from this study are in agreement with the early
benchmark trial. This finding strengthens the observation
that the interaction level of SNPs in pure epistasis models
is too high for CFS to handle. Similar to its predecessor,
the performance of TuRF still depends on both the
number of attributes and sample size. TuRF performs well
in the majority of simulation scenarios with 1,000-2,000
SNPs and 800-1,600 samples. These scenarios are rela-
tively easy since the number of SNPs is small while the
sample size is large. However, the size of output SNP set,
reported by TuRF from the null data problem and all three
interaction problems, increases significantly when the dif-
ficulty level rises by either reducing the sample size or
increasing the number of SNPs. This implies that when
the problem contains a large number of candidate SNPs,
the only way to ensure that TuRF reports a proper SNP set
is to use a relatively large sample size, making it impracti-
cal in real genetic association studies due to many factors
including disease prevalence, population size and geno-
typing cost.
The global p-values in most of the SAA results from the
null data problem and all three interaction problems
exceed 0.05, showing that SAA reports a low false-positive
result in the null data problem. Nonetheless, SAA remains
unsuitable for detecting pure epistasis because of its high
false-negative error. This poor performance can be traced
back to the manner in which SAA exploits an omnibus
permutation test. As stated earlier, single-locus analysis
does not detect any association between a SNP and the
disease in this study. Hoh et al. [11] have demonstrated
that genetic association can be more significantly
observed when the single-locus test statistics are com-
bined together. Nonetheless, there is an additional
requirement that each causative SNP must exhibit a mar-
ginal single-locus effect. In the current study, the associa-
tion signal from each causative SNP is lower than the
required threshold, leading to similar test statistics and
global p-values for both combinations of multiple SNPs
which include causative SNPs and those which exclude
causative SNPs.
Both 2LOmb and exhaustive two-locus analysis technique
are capable of identifying all causative SNPs. However, the
size of output SNP set from 2LOmb is significantly
smaller than that from the exhaustive two-locus analysis.
Appended SNPs to the causative SNPs in the output from
2LOmb and those from the exhaustive two-locus analysis
are erroneous SNPs. These erroneous SNPs are parts of
false two-SNP units with Bonferroni-corrected χ2's p-val-
Performance of the exhaustive two-locus analysis, SAA, CFS,  TuRF and 2LOmb in the null data problem Figure 2
Performance of the exhaustive two-locus analysis, 
SAA, CFS, TuRF and 2LOmb in the null data prob-
lem. The results are averaged over 25 independent simula-
tions. False detection is declared for the exhaustive two-
locus analysis, SAA and 2LOmb if the p-values used as detec-
tion indicators in their results are less than 0.05. The results 
from the exhaustive two-locus analysis (E2LA), SAA, CFS, 
TuRF and 2LOmb are displayed using magenta, blue, green, 
red and black markers, respectively. In each chart, the hori-
zontal axis represents the detection algorithm while the ver-
tical axis represents the number of output SNPs reported by 
the algorithm. The top nine charts are displayed using a finer 
scale than the bottom nine charts.
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ues less than 0.05. A similar trend of results regarding the
size of output SNP set is also observed in the benchmark
trial involving the application of 2LOmb and exhaustive
two-locus analysis to the null data. This signifies that the
permutation test and the progressive search embedded in
2LOmb can help reducing the number of erroneous SNPs
in the output.
As mentioned earlier, 2LOmb produces the best results
among five techniques in the benchmark trial. 2LOmb
has a low false-positive error in the null data problem and
is capable of detecting all causative SNPs in every simu-
lated data set in all three interaction problems. This per-
formance is further strengthened by highly significant
global p-values in 2LOmb results from all three interac-
tion problems (p < 0.0001) and the presence of a SNP in
common among some or all pairs of two-SNP units in the
three- and four-locus interaction problems. Nonetheless,
some of the 2LOmb outputs contain a few erroneous
SNPs which are irrelevant to the correct association expla-
nation. Since all three interaction problems involving dif-
ferent numbers of causative SNPs are investigated by
varying the total number of SNPs, the sample size and the
level of heritability, these parameters may influence the
number of erroneous SNPs in the 2LOmb results. Simi-
larly, the total number of SNPs and the sample size may
affect the number of erroneous SNPs in the 2LOmb results
from the null data problem. ANOVA reveals that the only
source of variation that significantly affects the number of
erroneous SNPs in the null data, two-locus interaction
and three-locus interaction problems is the sample size (p
< 0.000001). In addition, the sample size must be greater
than 800 for an increase in the number of erroneous SNPs
to be significant. In contrast, ANOVA reveals that two
sources of variation that affect the number of erroneous
SNPs in the four-locus interaction problem are the sample
size (p < 0.000001) and the total number of SNPs (p <
0.00005). Similar to the null data, two-locus interaction
and three-locus interaction problems, the sample size in
the four-locus interaction problem must be greater than
800 to create a significant increase in the number of erro-
neous SNPs. On the other hand, the number of erroneous
SNPs appears to decrease when the total number of SNPs
increases. These two sources of variation also interact with
each other (p < 0.005). However, the interaction is most
evident only when the sample size is large, i.e. when the
sample size is 1,600.
ANOVA shows that the number of erroneous SNPs in the
2LOmb results is influenced by the sample size and the
total number of SNPs but not by the heritability. It is
observed that the number of erroneous SNPs increases
when the sample size is large. This counterintuitive phe-
nomenon can be explained as follows. As 2LOmb com-
Performance of the exhaustive two-locus analysis and  2LOmb in the two-locus interaction problem Figure 3
Performance of the exhaustive two-locus analysis 
and 2LOmb in the two-locus interaction problem. 
The results are averaged over 25 independent simulations. 
Detection is declared for the exhaustive two-locus analysis 
and 2LOmb if the p-values used as detection indicators in 
their results are less than 0.05. The results from the exhaus-
tive two-locus analysis (E2LA) and 2LOmb are displayed 
using magenta and black markers, respectively. In each chart, 
the horizontal axis represents the detection algorithm while 
the vertical axis represents the number of output SNPs 
reported by the algorithm. All causative SNPs are present in 
outputs from both the exhaustive two-locus analysis and 
2LOmb in all simulations.
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bines  p-values that are determined from χ2  tests, the
number of entries for the contingency table construction
is large when the sample size is large. This subsequently
leads to a significantly large χ2 statistic and hence an
extremely small p-value if the SNPs under consideration
are causative SNPs. At the same time, the possibility that a
reasonably large χ2 statistic and a small p-value can be
obtained by chance from a two-SNP unit which is irrele-
vant to the correct association explanation also inevitably
increases. With the increase in the possibility of erroneous
SNP inclusion, the size of output SNP set gets bigger when
the sample size is large. Another observation that appears
to be counterintuitive is the reduction in the number of
erroneous SNPs when the total number of SNPs increases.
This phenomenon is the result of the Bonferroni correc-
tion usage. When the total number of SNPs is doubled,
the Bonferroni correction factor in 2LOmb is quadrupled.
A higher correction factor leads to a more stringent crite-
rion for SNP selection. This subsequently leads to the
reduction in the number of erroneous SNPs when the
total number of SNPs is large.
In contrast to the first two parameters, different levels of
heritability appear to have no effect on the 2LOmb results
because all simulated data sets have balanced case-control
samples and the embedded interaction models have the
same architecture. For instance, a two-locus interaction
model leads to zero penetrances for genotypes AABB,
AABb, AaBB, Aabb, aaBb and aabb. Hence, the penetrances
for these six genotypes are always equal to zero regardless
of the heritability. On the other hand, genotypes AAbb,
AaBb and aaBB have non-zero penetrances (see Methods
for details). Therefore, different heritability levels cer-
tainly lead to different penetrances for genotypes AAbb,
AaBb and aaBB. However, the ratios between the pene-
trances of these three genotypes are fixed and independ-
ent of the heritability. This model description can be
generalised to cover the other multi-locus interaction
models. In addition, the maximum penetrance in any
two-locus or multi-locus interaction models always stays
below 0.1 even though the heritability is at the highest
level (see Methods for details). This means that case sam-
ples are always over-sampled from affected individuals to
achieve a balanced case-control data set. Since all explored
heritability levels lead to the same case over-sampling pat-
tern, the simulated data sets of which the only primary
difference being the heritability levels are indistinguisha-
ble from one another. This leads to the result similarities
in interaction problems with the same number of SNPs in
the data set, sample size and number of causative SNPs
but different levels of heritability as shown in Figures 3, 4,
5, 6, 7 and 8. The result trend is also independent of the
number of simulated data sets used in the benchmark
trial.
Performance of SAA, CFS, TuRF and 2LOmb in the two- locus interaction problem Figure 4
Performance of SAA, CFS, TuRF and 2LOmb in the 
two-locus interaction problem. The results are averaged 
over 25 independent simulations. Detection is declared for 
SAA and 2LOmb if the p-values used as detection indicators 
in their results are less than 0.05. The results from SAA, CFS, 
TuRF and 2LOmb are displayed using blue, green, red and 
black markers, respectively. In each chart, the horizontal axis 
represents the number of correctly-identified causative SNPs 
while the vertical axis represents the number of output SNPs 
reported by the algorithm. The charts on which the red 
markers are invisible denote the situations in which the per-
formance of TuRF and 2LOmb is similar. The charts in this 
figure are displayed using a coarser scale than the charts in 
Figure 3.
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Performance of the exhaustive two-locus analysis and  2LOmb in the three-locus interaction problem Figure 5
Performance of the exhaustive two-locus analysis 
and 2LOmb in the three-locus interaction problem. 
The explanation for how the results are obtained and dis-
played is the same as that given in Figure 3.
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Performance of SAA, CFS, TuRF and 2LOmb in the three- locus interaction problem Figure 6
Performance of SAA, CFS, TuRF and 2LOmb in the 
three-locus interaction problem. The explanation for 
how the results are obtained and displayed is the same as 
that given in Figure 4.
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Performance of the exhaustive two-locus analysis and  2LOmb in the four-locus interaction problem Figure 7
Performance of the exhaustive two-locus analysis 
and 2LOmb in the four-locus interaction problem. 
The explanation for how the results are obtained and dis-
played is the same as that given in Figure 3.
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Performance of SAA, CFS, TuRF and 2LOmb in the four- locus interaction problem Figure 8
Performance of SAA, CFS, TuRF and 2LOmb in the 
four-locus interaction problem. The explanation for how 
the results are obtained and displayed is the same as that 
given in Figure 4.
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In a permutation test, the ability to differentiate between
two p-values is influenced by the number of permutation
replicates. With t permutation replicates, the test declares
an actual p-value that is less than 1/t to be zero. During the
progressive search for the best ensemble, the inclusion of
a new two-SNP unit is accepted if this inclusion does not
worsen the current result. If the number of permutation
replicates is too low, the search may include erroneous
two-SNP units that are irrelevant to the correct association
explanation. The analysis is confirmed as the number of
output SNPs from 2LOmb is equal to the number of caus-
ative SNPs in most of simulation results. This phenome-
non suggests that the number of permutation replicates
employed in this study (t = 10,000) is high enough to
screen off most of the erroneous two-SNP units. In other
words, the inclusion of these erroneous two-SNP units
leads to an increase in the p-value by at least 1/t. Nonethe-
less, the fact that 2LOmb results are not entirely free from
erroneous SNPs suggests that there are erroneous two-SNP
units with extremely small p-values. It is advisable to per-
form a genotype relative risk calculation for the elimina-
tion of erroneous SNPs. If the presence of an erroneous
two-SNP unit is suspected, its result on two-locus geno-
type relative risk would not be as significant as that from
the other two-SNP units in the ensemble. Alternatively, an
additional means for further SNP screening by other tech-
niques such as MDR is also recommended. The chance of
erroneous SNP discovery would be further minimised by
employing two consecutive attribute selection techniques.
The same concept has been adopted for the implementa-
tion of MDR software, in which many additional filters
including a χ2 test, an odds ratio test, ReliefF and TuRF are
available for SNP screening prior to the MDR analysis.
The two-, three- and four-locus interaction data sets which
have been screened for causative SNPs by 2LOmb are sub-
sequently subjected to MDR analysis. MDR has success-
fully identified all erroneous SNPs and the correct
interaction models have been constructed from all data
sets. The prediction accuracy from the MDR analysis is
illustrated in Figure 9. It is noted that the prediction accu-
racy from all data sets is quite high due to the manner in
which the pure epistasis model is defined [42]. Using the
penetrance table for a two-locus interaction model with
the heritability = 0.01 (see Methods for details), the two-
locus genotype distribution of causative SNPs in a bal-
anced case-control sample set from simulated data with
800 samples can be estimated and shown in Figure 10.
Six genotypes in Figure 10 namely AABB, AABb, AaBB,
Aabb, aaBb and aabb are protective genotypes. In other
words, a sample with one of these six genotypes is a con-
trol sample because the penetrances for these genotypes
are zero. It is also noted that the control samples with all
nine genotypes precisely follow the distribution as jointly
described by independent single-locus genotype distribu-
tion from loci A and B. In contrast, three remaining geno-
types in Figure 10 namely AAbb,  AaBb  and  aaBB  are
labelled as disease-predisposing genotypes because the
majority of samples with these three genotypes are case
samples. Samples with these genotypes may be either case
or control samples because the penetrances for these gen-
otypes are between zero and one. In fact, the probabilities
that persons with these genotypes to have the disease are
quite low since the penetrances for these genotypes are
small. However, case samples must be over-sampled from
affected individuals to ensure a balanced case-control data
set because the disease prevalence for this two-locus inter-
action model is only 0.004975. In addition, each case
sample must contain one of these three genotypes because
the penetrances for the other genotypes are zero. As a
result, the case samples with these genotypes do not fol-
low the same two-locus genotype distribution as in the
control samples. With six genotypes being exclusively spe-
cific to control samples and the majority of three remain-
ing genotypes being found in case samples, the MDR
prediction accuracy for the two-locus interaction model is
high. This explanation can also be generalised to cover the
MDR results from the other multi-locus interaction data
sets.
Another advantage of using 2LOmb for SNP screening
prior to the MDR analysis is the reduction in computa-
tional time for interaction detection. The computational
time for 2LOmb to finish screening the SNPs is provided
to demonstrate this strength of 2LOmb. Moreover, the
computational time required to identify causative SNPs
by the MDR analysis and that by the combined approach
which involves SNP screening by 2LOmb and follows by
the MDR analysis is given. The previously-described sim-
ulated data sets with causative SNPs are used to produce
the computational time results from the SNP screening by
2LOmb and the combined approach. All possible interac-
tion models that can be constructed from the 2LOmb out-
puts are explored by MDR in the combined approach. On
the other hand, the data sets for the direct MDR analysis
are prepared by restricting the number of SNPs in each
data set to 100. Only SNPs that are irrelevant to the correct
association explanation are removed from the original
simulated data sets. Furthermore, MDR only explores the
interaction models that do not cover more than four SNPs
in the data for this latter simulation setting. The summary
of computational time required for the SNP screening by
2LOmb and that for both direct MDR and combined
approaches to correctly identify all causative SNPs is given
in Table 1. The maximum time required by 2LOmb to
screen SNPs in the largest data set is 419 seconds or
approximately seven minutes. Moreover, the combined
2LOmb and MDR approach discovers the correct causa-
tive SNPs much faster than MDR. This time reduction isBMC Bioinformatics 2009, 10:294 http://www.biomedcentral.com/1471-2105/10/294
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achieved even though the problems have been simplified
for the direct MDR analysis. A direct application of MDR
to the original simulated data sets is certainly impractical.
The simulated multi-locus interaction problems in this
article are based on the pure epistasis model by Culver-
house et al. [42]. It is possible to capture a number of
multi-locus interactions with marginal two-locus effects
via a combination of two-locus analyses. However, there
are many multi-locus interaction scenarios without mar-
ginal two-locus effects. In such cases, 2LOmb and the
exhaustive two-locus analysis technique are unable to
detect interactions. Among the explored techniques, TuRF
and MDR have a better chance of detection. Nonetheless,
TuRF functions well only when the total number of SNPs
in data is small and the sample size is large enough while
the total number of SNPs in data affects the practicality of
direct MDR analysis.
Every attribute selection technique has a limitation in
terms of the maximum numbers of samples and attributes
that it can handle. Single-locus analysis techniques always
have a higher limit than multi-locus analysis techniques.
Because attribute subset evaluation is usually integrated
into multi-locus analysis techniques, consequently the
number of possible attribute subsets that can be explored
is extremely large when the candidate attribute set is large.
Together with a potentially large sample size, a higher
computational requirement for multi-locus analysis tech-
niques is inevitable. As a result, the direct application of
multi-locus analysis techniques to a much larger data set
than those presented in this article, which is usually con-
sidered in genome-wide association studies, would be
impractical. However, it is reasonable to expect that both
marginal single-locus and epistatic effects are present in
any genome-wide data sets. A multi-stage strategy that
incorporates multiple techniques, designed for different
detection modes, would be more suitable to handle large
data. For instance, the marginal single-locus effects should
be the first priority and, as such, be detected by single-
locus analysis. Then, a special case of pure epistasis [2] or
semi-purely epistatic events, in which a SNP displaying a
marginal single-locus effect interacts with a SNP that
exhibits no marginal single-locus effect, should be consid-
ered. Many two-locus analysis techniques have been
proven to be well suited to this type of epistasis
[40,50,51]. Finally, the detection of pure epistasis is car-
ried out in the last stage. With the reduction of SNPs from
the first stage, the chance that some multi-locus analysis
techniques are applicable to the remaining SNPs
increases. In addition to the multi-stage approach, a prior
knowledge regarding the previously reported association
can be exploited to select candidate genes based upon
ontology and pathways. This practice is due to the neces-
sity for the derivation of plausible interpretation. The
screening for SNPs within or near candidate genes before
the association detection also increases the chance that
multi-locus analysis techniques can be applied to the
remaining data.
Testing with real data
2LOmb has been applied to study a type 2 diabetes melli-
tus (T2D) data set, collected and investigated by the Well-
come Trust Case Control Consortium (WTCCC) [3]. The
data set consists of 1,999 case samples from affected indi-
viduals in the UK and 3,004 control samples, which are
the results of a merging between 1,500 samples from the
UK blood services and 1,504 samples from the 1958 Brit-
ish birth cohort. The original genome-wide data set con-
tains 500,568 SNPs that are obtained through the
Affymetrix GeneChip 500 K Mapping Array Set. The SNP
set is primarily reduced by screening for SNPs within and
near 372 candidate genes collected by the Human
Genome Epidemiology Network (HuGENet) [62]. These
candidate genes cover genes from both positive and nega-
tive genetic association reports, in which studies are con-
ducted in various ethnic groups and populations. The SNP
set is further reduced by removing SNPs that exhibit
Prediction accuracy from the MDR analysis Figure 9
Prediction accuracy from the MDR analysis. A 10-fold 
cross-validation strategy is applied during the accuracy evalu-
ation. The best MDR model is located by exploring all possi-
ble SNP combinations. All erroneous SNPs, which are left 
over after the screening by 2LOmb, have been successfully 
identified. All MDR models contain the correct number of 
causative SNPs. In addition, the MDR cross-validation con-
sistency is 10/10.
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strong evidence of genetic association via single-locus
analysis. The final SNP set contains 7,065 SNPs from 370
candidate genes. All SNPs in the reduced data set exhibit
no marginal single-locus effects (Bonferroni-corrected χ2's
p-value > 0.05). Detailed description of the final SNP set
is given in the supplement (see Additional file 1).
The 2LOmb search in the reduced T2D data set takes
3,456 seconds (57.6 minutes) of computational time on
the Beowulf cluster. The possible genetic association is
detected from 11 intronic SNPs in four genes (global p-
value < 0.0001). Details of these SNPs, the two-SNP units
that exhibit marginal two-locus effects and the identified
genes are given in Table 2. A two-SNP unit is located in
LMX1A. A two-SNP unit is also detected in PARK2. In
addition, there is one SNP in common among SNPs in
both GYS2 two-SNP units. Similarly, there is one com-
mon SNP among three two-SNP units located in PGM1.
Nonetheless, a two-SNP unit in which each SNP is located
in a different gene is absent, indicating that there is no evi-
dence of gene-gene interactions which can be observed
from the 2LOmb result. Linkage disequilibrium (LD)
analysis is subsequently performed using a JLIN package
[63] and the resulting LD patterns are illustrated in Figure
11. It is noted that there is strong LD among SNPs within
each gene due to high values of D' [64] and r2 [65]. The
genotype and haplotype relative risks are then calculated
and the results are presented in Tables 3, 4, 5, 6, 7, 8, 9 and
10. Haplotype inference is carried out using an expecta-
tion-maximisation method [66]. The analysis reveals that
a more prominent indication of a relative risk is observed
when two-SNP units are considered. It is also noted that
the genotype relative risk is directly influenced by the hap-
lotype relative risk once a genotype is phased into all pos-
sible haplotype pairs. The detection of these two-SNP
units is thus believed to be the consequence of haplotype
effects. An early T2D association study also reveals similar
haplotype effects in FUSION data [67]. Next, an interac-
tion dendrogram [68,69] constructed from the 11 SNPs
by MDR software is given in Figure 12. A strong synergistic
effect between the two SNPs in PARK2 is clearly observed.
In contrast, the interactions between PGM1,  LMX1A,
PARK2 and GYS2 are clearly absent.
Since many early genetic association studies of T2D and
metabolic syndrome employ MDR analysis [43-45,47],
additional MDR analysis would be useful for the compar-
ison. The screened T2D case-control data set which con-
tains 11 SNPs identified by 2LOmb is further subjected to
MDR analysis. The prediction accuracy of the best MDR
model is summarised in Table 11. The model covers six
SNPs in three genes: PGM1, PARK2 and GYS2. These SNPs
are also present in three two-SNP units identified by
2LOmb. It is noted that the prediction accuracy in this real
data set is much less than that from the simulated data
sets. Nevertheless, the attainment of low prediction accu-
racy does not necessarily suggest that there is no genetic
association. Early works involving genetic association
studies of T2D and metabolic syndrome in various popu-
lations via MDR analysis produce similar values of predic-
tion accuracy as summarised in Table 12. The prediction
accuracy by MDR from most studies is in the range of 0.5-
0.6. The only genetic association study of T2D that the
prediction accuracy is distinctively high is conducted in a
Korean population [43]. Differences in genetic back-
ground, candidate genes and selected SNPs are the main
causes of variation in the genetic association results.
Although MDR does not select five SNPs from the 2LOmb
output, these SNPs should not be regarded as erroneous
SNPs because there is strong linkage disequilibrium
among SNPs in each gene. Moreover, early genotype and
haplotype relative risk analysis clearly indicates that each
gene, identified by 2LOmb, plays a role in the T2D associ-
ation explanation. Overall, the analysis with the methods
above only confirms the positive association for PGM1,
LMX1A, PARK2 and GYS2 while gene-gene interactions
are clearly absent. This signifies that, for the current study,
there is no interaction between each pair of the identified
genes that can be described by purely epistatic two-locus
interaction models. In addition, there are no interactions
Genotype distribution of two causative SNPs in a balanced  case-control data set with the sample size of 800 Figure 10
Genotype distribution of two causative SNPs in a bal-
anced case-control data set with the sample size of 
800. The left (black) bar in each cell represents the number 
of case samples while the right (white) bar represents the 
number of control samples. The cells with genotypes AABB, 
AABb, AaBB, Aabb, aaBb and aabb are labelled as protective 
genotypes while the cells with genotypes AAbb, AaBb and 
aaBB are labelled as disease-predisposing genotypes.
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between these four genes that can be described by purely
epistatic multi-locus interaction models with marginal
two-locus effects.
The four genes selected by 2LOmb regulate many path-
ways that involve in the disease development [70-72]. The
genetic association studies involving these genes have
been previously conducted in different populations. For
instance, LMX1A has been chosen as a positional and bio-
logical candidate gene for a case-control study of T2D in
Pima Indians [73]. This gene is chosen as a candidate
because a linkage of T2D to chromosome 1q21-q23 has
been previously reported [74]. In addition, LMX1A is one
of LIM homeobox genes that are expressed in pancreas
and has been shown to activate insulin gene transcription.
Although SNPs have been carefully selected from the
entire gene, no association between these SNPs in LMX1A
and T2D has been found in this ethnic group.
PARK2 is another candidate gene that is also selected for
case-control studies, based on evidence from genome-
wide linkage analysis [75]. A linkage of T2D in an African
American population to chromosome 6q24-q27 has been
previously identified [76]. Although PARK2  mainly
involves in the development of Parkinson's disease, sin-
gle-locus analysis reveals strong evidence of association
between SNPs, which are in the vicinity of SNPs identified
by 2LOmb, and T2D in African Americans.
In contrast to LMX1A and PARK2, which are candidate
genes in typical T2D case-control studies, GYS2 is consid-
ered in a study to identify genes responsible for troglita-
zone-associated hepatotoxicity in Japaneses with T2D
[77]. In other words, both case and control samples in the
study are drawn from troglitazone-treated T2D patients,
in which case patients exhibit an abnormal increase in
alanine transaminase (ALT) and aspartate transaminase
(AST) levels. GYS2 regulates starch and sucrose metabo-
lism and an insulin signalling pathway. The selected SNPs
in  GYS2  are not found to associate with troglitazone-
induced hepatotoxicity.
Similar to the study of GYS2, the association study involv-
ing PGM1 is not carried out as a typical T2D case-control
study. In fact, an attempt to identify association between
PGM1 polymorphisms and obesity has been conducted
among T2D affected individuals in Italy [78]. PGM1 regu-
lates glycolysis and gluconeogenesis, starch and sucrose
metabolism, galactose metabolism, a pentose phosphate
pathway, and streptomycin biosynthesis. Isozyme poly-
morphisms [79,80], which are defined through structural
differences in PGM1 protein, are used instead of SNPs in
the study where positive association is identified.
In summary, positive association has been reported from
previous studies involving PARK2 in African Americans
and PGM1 in Italians. In contrast, negative association has
been reported from previous studies about LMX1A  in
Pima Indians and GYS2  in Japaneses. Both GYS2  and
PGM1  regulate starch and sucrose metabolism while
LMX1A and PARK2 govern insulin gene transcription and
Parkinson's disease development, respectively. The above
discussion strengthens the importance of conducting
large-scale association studies due to two main reasons.
Firstly, a gene that does not contribute to the aetiology of
a complex disease in one population may be important
for association explanation in another population. Sec-
ondly, the absence of interacting candidate genes from a
study may lead to negative association due to a lack of
necessary genetic information. A two-locus interaction
Table 1: Computational time required by 2LOmb, a combined 2LOmb and MDR approach, and direct MDR analysis to detect 
interactions in simulated data sets with different sizes and different numbers of causative SNPs.
Computational Time Required by Each Approach (sec)
2LOmb 2LOmb+MDR MDR
Number of 
Causative SNPs
Sample Size 1,000 SNPs 2,000 SNPs 4,000 SNPs 1,000 SNPs 2,000 SNPs 4,000 SNPs 100 SNPs
2 400 15 37 135 17 39 137 7,656
800 21 59 224 23 61 226 15,990
1,600 36 106 400 38 108 402 31,222
3 400 22 43 140 24 45 142 7,721
800 30 65 229 32 67 231 16,206
1,600 50 115 406 52 117 408 31,232
4 400 32 55 150 34 57 152 7,841
800 46 80 236 48 82 238 16,285
1,600 70 133 419 72 135 421 31,637
Only one computing processor in a Beowulf cluster is occupied during the analysis of one data set. The test problems for the direct MDR analysis 
have been simplified by reducing the number of SNPs in each data set to achieve attainable computational time. The displayed time is collected from 
the processing of multiple independent data sets for each simulation setting. The computational time from the benchmark trial involving 2LOmb, 
and the combined 2LOmb and MDR approach is the maximum time needed by each method to detect interactions in one data set. In contrast, the 
computational time from the direct MDR analysis is the minimum time for the completion of interaction detection in one data set. The 
computational time required by 2LOmb for the null data problem is similar to that for the two-locus interaction problem.BMC Bioinformatics 2009, 10:294 http://www.biomedcentral.com/1471-2105/10/294
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can occur between SNPs from genes that regulate one spe-
cific pathway [44] or between SNPs from genes that regu-
late different pathways [45]. Furthermore, a multi-locus
interaction may involve both SNPs from genes that regu-
late the same pathway and SNPs from genes that govern
different pathways. Hence, candidate genes should be
selected by considering all pathways that directly and
indirectly contribute to the disease development.
This study produces evidence of association between 11
intronic SNPs in PGM1, LMX1A, PARK2 and GYS2, and
T2D in a UK population. Although there are other inde-
pendent genome-wide T2D data sets, the association
detection within these data using a similar methodology
to the presented method has never been attempted
because the methodology employed in the majority of
genome-wide association studies is based on single-locus
analysis [3,81]. It is recalled that each SNP explored in the
reduced T2D data set exhibits no marginal single-locus
effect. Hence, the most logical approach to confirm the
possibility of replicating association results from the cur-
rent study is to perform the same detection method on
these independent data sets. This is certainly important to
gain further understanding of the genetic role in T2D sus-
ceptibility.
Implementation
2LOmb is implemented in a C programming language.
All functions within the program are written by the first
author except the χ2 distribution function, which is taken
from the Numerical Recipes in C [82]. The program can be
compiled by Microsoft Visual Studio and GNU C compil-
ers. The program has been successfully tested for the exe-
cution under Windows and Linux operating systems. The
time required by 2LOmb to complete a problem contain-
ing n attributes is T (n) =   = n!/((n - 2)!2!) = n(n - 1)/
2. 2LOmb thus has the order of n2 time complexity (T (n)
∈ O(n2)). Consequently, 2LOmb can tackle problems in
quadratic time. 2LOmb in its present form occupies one
processor during the program execution. A parallel ver-
sion of 2LOmb for genome-wide data is under develop-
ment. All results included in the study are collected from
the execution of computer programs in a Beowulf cluster.
The computational platform consists of 12 nodes. Each
node is equipped with dual Xeon 2.8 GHz processors and
4GB of main memory. The Rocks Cluster Distribution is
installed on all nodes.
Conclusion
In this article, a method for detecting epistatic multi-locus
interactions in case-control data is presented. The study
focuses on pure epistasis [2], which cannot be detected via
single-locus analysis [42]. To overcome this difficulty, the
proposed method performs an omnibus permutation test
[54] on ensembles of two-locus analyses and is thus
referred to as 2LOmb. The detection performance of
2LOmb is evaluated using both simulated and real data.
From the simulation, 2LOmb produces a low false-posi-
tive error when the tests on null data of no association are
performed. Furthermore, 2LOmb can identify all causa-
tive SNPs and outperforms a simple exhaustive two-locus
analysis technique, a set association approach (SAA) [11],
a correlation-based feature selection (CFS) technique [14]
and a tuned ReliefF (TuRF) technique [16] in various
interaction scenarios with marginal two-locus effects.
These scenarios are set up by varying the number of caus-
ative SNPs, the number of SNPs in data, the sample size
and the heritability. ANOVA reveals that the number of
SNPs in data and the sample size influence the number of
erroneous SNPs appended to the correctly-identified caus-
ative SNPs in the 2LOmb output. In contrast, the results
from 2LOmb appear to be insensitive to the variation in
heritability. After subjecting the data sets containing only
SNPs that are screened by 2LOmb to multifactor dimen-
sionality reduction (MDR) analysis [19], all erroneous
SNPs are successfully removed. In addition, an insight
into the MDR models is provided. 2LOmb is subsequently
applied to a real case-control type 2 diabetes mellitus
(T2D) data set, which is collected from a UK population
by the Wellcome Trust Case Control Consortium
(WTCCC) [3]. The original genome-wide data set is first
reduced by selecting only SNPs that locate within or near
372 candidate genes reported by the Human Genome Epi-
demiology Network (HuGENet) [62]. In addition, the
selected SNPs must exhibit no marginal single-locus
effects. The final data set, which consists of 1,999 case
samples and 3,004 control samples, contains 7,065 SNPs
from 370 candidate genes. 2LOmb identifies 11 intronic
SNPs that are associated with the disease. These SNPs are
located in PGM1, LMX1A, PARK2 and GYS2. The 2LOmb
result suggests that there is no interaction between each
pair of the identified genes that can be described by purely
epistatic two-locus interaction models. Moreover, there
are no interactions between these four genes that can be
described by purely epistatic multi-locus interaction mod-
els with marginal two-locus effects. This evidence of
genetic association for these four genes leads to an alter-
native explanation for the aetiology of T2D in the UK pop-
ulation. It also implies that SNPs from genome-wide data
which are usually discarded after single-locus analysis
confirms the null hypothesis of no association can still be
useful for genetic association studies of complex diseases.
Methods
Pure epistasis model
The pure epistasis model of interest is proposed by Culver-
house et al. [42]. The model describes a restriction or con-
straint for penetrance of each genotype constituting the
n
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Linkage disequilibrium (LD) patterns of SNPs in PGM1, LMX1A, PARK2 and GYS2 Figure 11
Linkage disequilibrium (LD) patterns of SNPs in PGM1, LMX1A, PARK2 and GYS2. LD is explained via D' displayed in 
the upper triangle and r2 displayed in the lower triangle. Dark colours indicate high values while pale colours indicate low val-
ues. Distances between SNPs are given in terms of the number of base pairs. SNP1 = rs2269241, SNP2 = rs2269239, SNP3 = 
rs3790857, SNP4 = rs2269238, SNP5 = rs2348250, SNP6 = rs6702087, SNP7 = rs1893551, SNP8 = rs6924502, SNP9 = 
rs6487236, SNP10 = rs1871142 and SNP11 = rs10770836.
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interaction model. Consider a two-locus model that cap-
tures an interaction between loci A and B, let A and a be
the major (common) and minor (rare) alleles at locus A.
Similarly, let B and b be the major and minor alleles at
locus B. At each locus, the genotype is represented by char-
acters 0, 1 or 2 where 0 denotes a homozygous wild-type
genotype (AA and BB), 1 denotes a heterozygous geno-
type (Aa and Bb) and 2 denotes a homozygous variant or
homozygous mutant genotype (aa and bb). fij ∈ [0, 1] is
defined as the disease penetrance of the two-locus geno-
type ij that consists of genotype i at locus A and genotype
j at locus B. The marginal penetrances MAi for genotype i
at locus A and MBj for genotype j at locus B are given by
and
where pA and pB are the major allele frequencies. Equations
4 and 5 are usually represented by a penetrance table as
illustrated in Table 13. The two-locus interaction model is
a pure epistasis model if
Mp f p p f p f i Ai B i B B i B i =+− + − ∈
2
01
2
2 21 1 0 1 2 () () , { , , } ,
(4)
Mp f p p f pf j Bj A j A A j A j =+− + − ∈
2
01
2
2 21 1 0 1 2 () () , { , , } ,
(5)
Interaction dendrogram produced from 11 SNPs that are chosen by 2LOmb Figure 12
Interaction dendrogram produced from 11 SNPs that are chosen by 2LOmb. The colours in the dendrogram com-
prise a spectrum of colours representing a transition from synergy to redundancy. Synergy denotes the situation in which the 
entropy-based interaction between two SNPs provides more information than the entropy-based correlation between the 
pair. Redundancy refers to the situation in which the entropy-based interaction between two SNPs provides less information 
than the entropy-based correlation between the pair [7].
Synergy
Redundancy
LMX1A
LMX1A
GYS2
GYS2
GYS2
PARK2
PARK2
PGM1
PGM1
PGM1
PGM1
rs2348250
rs6702087
rs6487236
rs1871142
rs10770836
rs1893551
rs6924502
rs2269241
rs2269239
rs3790857
rs2269238
Table 2: 2LOmb identifies 11 intronic SNPs, which are located in four genes, from the reduced T2D data.
Gene Chromosome and Location Two-SNP Unit in the Ensemble
PGM1 (phosphoglucomutase 1) 1p31 (rs2269241, rs3790857)
(rs2269239, rs3790857)
(rs3790857, rs2269238)
LMX1A (LIM homeobox transcription factor 1, alpha) 1q22-q23 (rs2348250, rs6702087)
PARK2 (Parkinson disease (autosomal recessive, juvenile) 2, parkin) 6q25.2-q27 (rs1893551, rs6924502)
GYS2 (glycogen synthase 2 (liver)) 12p12.2 (rs6487236, rs1871142)
(rs1871142, rs10770836)
Association between these SNPs and the disease is possible (global p-value < 0.0001). Seven two-SNP units are present in the ensemble where each 
unit contains a pair of SNPs from the same gene.BMC Bioinformatics 2009, 10:294 http://www.biomedcentral.com/1471-2105/10/294
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where K is the disease prevalence. Obviously, many com-
binations of penetrance fij satisfy the condition given in
equation 6. Culverhouse et al. [42] suggest that a pure
epistasis model with the maximum heritability is particu-
larly useful in association studies. The heritability (h2) of
the two-locus interaction model is defined by
where VT = K(1 - K) is the total variance of the dichoto-
mous phenotypes in the population and VI is the epistatic
variation attributable to the genotypes. VI is defined by
The search for feasible penetrance fij that also maximises
the heritability or other variance-based objectives can be
treated as a constraint optimisation problem. Many algo-
rithms including a double description method [42] and a
genetic algorithm [83] have been proven to be suitable for
the task.
Culverhouse et al. [42] have identified the maximum her-
itability of purely epistatic two-locus and multi-locus
interaction models for various values of disease preva-
lence. For instance, the maximum heritability of a two-
MMK i j Ai Bj == ∀ ∈ ,, { , , } , 012 (6)
hV V IT
2 = /, (7)
V p p f K p pp f K pp f K IA B A B B A B =− + − − + − −
+
22
00
22
01
22 2
02
2 21 1 ( ) () ( ) () ( )
2 21 41 1 21
2
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2
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2 p p p f Kp p p p f Kp p AA B AA BB AA () ( ) () () ( ) () ( − − +− − − +− 1 1
12 1 1
2
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+− − + − − −
pf K
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AB AB B
)( )
() ( ) () () ( )
2 22 2
22
2 11 +− − − () () ( ) . pp f K AB
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Table 3: Genotype relative risk evaluated from genotype distribution of SNPs in PGM1.
Frequency
SNP Genotype Case Control Relative Risk 95% CI
SNP1 0 0.6513 0.6528 0.9977 (0.9573-1.0399)
1 0.3082 0.3076 1.0018 (0.9204-1.0905)
2 0.0405 0.0396 1.0229 (0.7757-1.3488)
SNP2 0 0.6493 0.6521 0.9957 (0.9552-1.0379)
1 0.3087 0.3079 1.0024 (0.9209-1.0910)
2 0.0420 0.0399 1.0519 (0.8006-1.3822)
SNP3 0 0.6153 0.6568 0.9368 (0.8972-0.9782)
1 0.3472 0.3056 1.1361 (1.0479-1.2316)
2 0.0375 0.0376 0.9974 (0.7490-1.3281)
SNP4 0 0.6638 0.6668 0.9956 (0.9564-1.0364)
1 0.2991 0.2969 1.0074 (0.9237-1.0988)
2 0.0370 0.0363 1.0202 (0.7636-1.3631)
(SNP1, SNP3) 0 0 0.6043 0.6448 0.9372 (0.8966-0.9796)
0 1 0.0470 0.0080 5.8858 (3.7730-9.1816)
1 0 0.0110 0.0120 0.9183 (0.5420-1.5561)
1 1 0.2961 0.2943 1.0064 (0.9222-1.0983)
1 2 0.0010 0.0013 0.7514 (0.1378-4.0984)
2 1 0.0040 0.0033 1.2022 (0.4753-3.0408)
2 2 0.0365 0.0363 1.0064 (0.7523-1.3463)
(SNP2, SNP3) 00 0.6038 0.6448 0.9364 (0.8958-0.9789)
01 0.0455 0.0073 6.2159 (3.9154-9.8681)
10 0.0115 0.0117 0.9875 (0.5853-1.6661)
11 0.2966 0.2949 1.0058 (0.9218-1.0975)
12 0.0005 0.0013 0.3757 (0.0420-3.3588)
21 0.0050 0.0033 1.5028 (0.6266-3.6038)
22 0.0370 0.0363 1.0202 (0.7636-1.3631)
(SNP3, SNP4) 00 0.6138 0.6551 0.9369 (0.8971-0.9785)
01 0.0015 0.0017 0.9017 (0.2157-3.7686)
10 0.0500 0.0117 4.2936 (2.9340-6.2831)
11 0.2971 0.2936 1.0121 (0.9274-1.1044)
21 0.0005 0.0017 0.3006 (0.0351-2.5706)
22 0.0370 0.0360 1.0297 (0.7702-1.3765)
The relative risk is calculated from the ratio between the probability of a genotype of interest occurring in the case group and that of the same 
genotype occurring in the control group. Only the relative risks based on genotypic information from each SNP and SNP pairs identified by 2LOmb 
are considered. Characters 0, 1 and 2 represent different genotypes at each locus where 0 denotes a homozygous wild-type genotype, 1 denotes a 
heterozygous genotype and 2 denotes a homozygous variant or homozygous mutant genotype. The relative risk displayed in boldface is statistically 
significant. The major/minor alleles for rs2269241, rs2269239, rs3790857 and rs2269238 are T/C, G/C, C/T and G/T, respectively. The allelic 
information is extracted from the original T2D data. SNP1 = rs2269241, SNP2 = rs2269239, SNP3 = rs3790857 and SNP4 = rs2269238.BMC Bioinformatics 2009, 10:294 http://www.biomedcentral.com/1471-2105/10/294
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locus interaction model for pA = pB = 0.5 with the pene-
trances in Table 14 is
When a two-locus interaction model is expanded into a
multi-locus interaction model, the marginal penetrance
equality constraint must be extended to cover all loci. Fur-
thermore, the expression for VI must also be expanded to
cover additional genotypes while the expression for VT
remains unchanged. With the necessary model expansion,
the maximum heritability of a three-locus interaction
model for pA = pB = pC = 0.5 with the penetrances in Table
15 is given by
hK K K K max() / ( ) , (,/] .
2 21 0 1 4 =− ∈ (9)
hK K K K max() / ( ) , (,/ ] .
2 91 0 1 1 6 =− ∈ (10)
Table 4: Haplotype relative risk evaluated from genotype distribution of SNPs in PGM1.
Frequency
SNP Allele and Haplotype Case Control Relative Risk 95% CI
SNP1 0 0.8054 0.8066 0.9985 (0.9791-1.0183)
1 0.1946 0.1934 1.0061 (0.9274-1.0916)
SNP2 0 0.8037 0.8061 0.9970 (0.9775-1.0168)
1 0.1963 0.1939 1.0126 (0.9336-1.0982)
SNP3 0 0.7889 0.8096 0.9744 (0.9550-0.9943)
1 0.2111 0.1904 1.1087 (1.0240-1.2003)
SNP4 0 0.8134 0.8152 0.9977 (0.9789-1.0170)
1 0.1866 0.1848 1.0100 (0.9288-1.0982)
(SNP1, SNP3) 0 0 0.7812 0.8019 0.9742 (0.9543-0.9945)
0 1 0.0242 0.0047 5.1533 (3.3946-7.8231)
1 0 0.0077 0.0077 1.0000 (0.6349-1.5752)
1 1 0.1869 0.1857 1.0064 (0.9257-1.0941)
(SNP2, SNP3) 00 0.7804 0.8017 0.9734 (0.9535-0.9938)
01 0.0232 0.0044 5.3216 (3.4557-8.1949)
10 0.0085 0.0079 1.0758 (0.6930-1.6701)
11 0.1879 0.1861 1.0099 (0.9291-1.0977)
(SNP3, SNP4) 00 0.7881 0.8086 0.9747 (0.9552-0.9946)
01 0.0008 0.0010 0.7661 (0.1943-3.0205)
10 0.0253 0.0067 3.7936 (2.6367-5.4582)
11 0.1858 0.1837 1.0113 (0.9298-1.0999)
The relative risk is calculated from the ratio between the probability of a haplotype of interest occurring in the case group and that of the same 
haplotype occurring in the control group. Haplotype inference is carried out using an expectation-maximisation method. Only the relative risks 
based on genotypic information from each SNP and SNP pairs identified by 2LOmb are considered. Characters 0 and 1 represent different alleles at 
each locus where 0 and 1 denote major and minor alleles, respectively. The relative risk displayed in boldface is statistically significant. The allelic 
information for each SNP is given in Table 3. SNP1 = rs2269241, SNP2 = rs2269239, SNP3 = rs3790857 and SNP4 = rs2269238.
Table 5: Genotype relative risk evaluated from genotype distribution of SNPs in LMX1A.
Frequency
SNP Genotype Case Control Relative Risk 95% CI
SNP5 0 0.8429 0.8642 0.9754 (0.9526-0.9987)
1 0.1531 0.1315 1.1642 (1.0140-1.3366)
2 0.0040 0.0043 0.9248 (0.3840-2.2271)
SNP6 0 0.8799 0.8492 1.0362 (1.0135-1.0594)
1 0.1161 0.1465 0.7924 (0.6829-0.9193)
2 0.0040 0.0043 0.9248 (0.3840-2.2271)
(SNP5, SNP6) 00 0.8329 0.8299 1.0036 (0.9784-1.0295)
01 0.0100 0.0343 0.2918 (0.1814-0.4695)
10 0.0470 0.0193 2.4355 (1.7644-3.3618)
11 0.1061 0.1119 0.9482 (0.8061-1.1153)
22 0.0040 0.0040 1.0018 (0.4103-2.4465)
The explanation for how the relative risks are obtained and displayed is the same as that given in Table 3. The major/minor alleles for rs2348250 
and rs6702087 are G/A and G/C, respectively. The allelic information is extracted from the original T2D data. SNP5 = rs2348250 and SNP6 = 
rs6702087.BMC Bioinformatics 2009, 10:294 http://www.biomedcentral.com/1471-2105/10/294
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Similarly, the maximum heritability of a four-locus inter-
action model for pA = pB = pC = pD = 0.5 with the pene-
trances in Table 16 is
Additional details about the maximum heritability and
the corresponding two-locus and multi-locus penetrance
tables for other values of disease prevalence can be found
in Culverhouse et al. [42]. In this article, the simulated
data sets are generated to achieve the maximum heritabil-
ity of 0.01, 0.025 and 0.05. The values of disease preva-
lence that lead to the target heritability for two-, three- and
four-locus interaction models are given in Table 17.
genomeSIM
genomeSIM is a simulation package for generating case-
control samples in large-scale and genome-wide associa-
tion studies [60]. The package is capable of producing
many realistic scenarios, which can be observed in a pop-
ulation and genetic samples, including linkage disequilib-
rium, phenocopy and genotyping errors. The case/control
status of each sample is determined from the penetrance-
based genetic models or interaction models. As a result,
the package can accommodate many epistasis models
including the one proposed by Culverhouse et al. [42]. A
data set can be produced via two modes: a population-
based simulation and a probability-based simulation. In
the population-based simulation, an initial population is
generated according to the predefined allele frequency of
each SNP. Then further generations are created by crossing
the genotype strings within successive generations until
the specified number of generations is reached. The result-
ing data set contains a population-dependent case and
control samples that follow a forward-time simulation
strategy. In contrast, genotype strings are incrementally
generated without any string crossing for only one gener-
ation in the probability-based simulation. The creation of
new strings is terminated only when the desired numbers
hK K K K max() / ( ) , (,/ ] .
2 35 1 0 1 64 =− ∈ (11)
Table 6: Haplotype relative risk evaluated from genotype distribution of SNPs in LMX1A.
Frequency
SNP Allele and Haplotype Case Control Relative Risk 95% CI
SNP5 0 0.9195 0.9299 0.9887 (0.9774-1.0002)
1 0.0805 0.0701 1.1494 (0.9997-1.3214)
SNP6 0 0.9380 0.9224 1.0168 (1.0059-1.0279)
1 0.0620 0.0776 0.7997 (0.6892-0.9280)
(SNP5, SNP6) 00 0.9143 0.9124 1.0021 (0.9898-1.0145)
01 0.0051 0.0175 0.2931 (0.1829-0.4697)
10 0.0236 0.0100 2.3640 (1.7150-3.2585)
11 0.0569 0.0601 0.9472 (0.8064-1.1127)
The explanation for how the relative risks are obtained and displayed is the same as that given in Table 4. The allelic information for each SNP is 
given in Table 5. SNP5 = rs2348250 and SNP6 = rs6702087.
Table 7: Genotype relative risk evaluated from genotype distribution of SNPs in PARK2.
Frequency
SNP Genotype Case Control Relative Risk 95% CI
SNP7 0 0.4802 0.5110 0.9398 (0.8873-0.9954)
1 0.4322 0.4041 1.0695 (1.0008-1.1429)
2 0.0875 0.0849 1.0313 (0.8581-1.2395)
SNP8 0 0.4892 0.4923 0.9937 (0.9380-1.0527)
1 0.4087 0.4121 0.9917 (0.9267-1.0613)
2 0.1021 0.0955 1.0682 (0.9009-1.2665)
(SNP7, SNP8) 00 0.4492 0.4844 0.9275 (0.8726-0.9858)
01 0.0285 0.0260 1.0982 (0.7841-1.5380)
02 0.0025 0.0007 3.7569 (0.7296-19.3450)
10 0.0400 0.0080 5.0092 (3.1856-7.8767)
11 0.3792 0.3848 0.9854 (0.9169-1.0590)
12 0.0130 0.0113 1.1492 (0.6918-1.9089)
21 0.0010 0.0013 0.7514 (0.1378-4.0984)
22 0.0865 0.0836 1.0358 (0.8606-1.2465)
The explanation for how the relative risks are obtained and displayed is the same as that given in Table 3. The major/minor alleles for rs1893551 
and rs6924502 are G/A and T/C, respectively. The allelic information is extracted from the original T2D data. SNP7 = rs1893551 and SNP8 = 
rs6924502.BMC Bioinformatics 2009, 10:294 http://www.biomedcentral.com/1471-2105/10/294
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of case and control samples are obtained. In this study,
the probability-based simulation is used to produce all
case and control samples where the simulation parameter
setting is given in the supplement (see Additional file 2).
genomeSIM is available upon request to Scott M. Dudek
at the Vanderbilt University dudek@chgr.mc.vander-
bilt.edu.
Set association approach
A set association approach (SAA) is an association detec-
tion technique based on an omnibus permutation test on
sets of candidate SNPs [11]. The test captures information
about genotyping errors, deviation from Hardy-Weinberg
equilibrium (HWE) and allelic association. In the first
step, the genotype distribution for each SNP in the control
samples is checked for HWE. Then, the number of SNPs
that is to be excluded from the study (nd) is set to the
number of SNPs in the control samples that deviate from
HWE. Two test statistics are subsequently calculated for
each SNP: an allelic association statistic and a statistic for
the deviation from HWE of each SNP in the case samples.
The allelic association statistic is a χ2 statistic which is cal-
Table 8: Haplotype relative risk evaluated from genotype distribution of SNPs in PARK2.
Frequency
SNP Allele and Haplotype Case Control Relative Risk 95% CI
SNP7 0 0.6963 0.7130 0.9766 (0.9515-1.0023)
1 0.3037 0.2870 1.0582 (0.9950-1.1254)
SNP8 0 0.6936 0.6984 0.9931 (0.9672-1.0198)
1 0.3064 0.3016 1.0159 (0.9563-1.0793)
(SNP7, SNP8) 00 0.6726 0.6937 0.9696 (0.9434-0.9966)
01 0.0238 0.0194 1.2248 (0.9369-1.6011)
10 0.0210 0.0048 4.4215 (2.8972-6.7480)
11 0.2826 0.2822 1.0016 (0.9397-1.0675)
The explanation for how the relative risks are obtained and displayed is the same as that given in Table 4. The allelic information for each SNP is 
given in Table 7. SNP7 = rs1893551 and SNP8 = rs6924502.
Table 9: Genotype relative risk evaluated from genotype distribution of SNPs in GYS2.
Frequency
SNP Genotype Case Control Relative Risk 95% CI
SNP9 0 0.6473 0.6575 0.9846 (0.9447-1.0262)
1 0.3167 0.3046 1.0396 (0.9558-1.1308)
2 0.0360 0.0379 0.9491 (0.7105-1.2679)
SNP10 0 0.5933 0.6441 0.9211 (0.8805-0.9634)
1 0.3712 0.3169 1.1713 (1.0839-1.2657)
2 0.0355 0.0389 0.9119 (0.6828-1.2180)
SNP11 0 0.6058 0.6142 0.9864 (0.9427-1.0321)
1 0.3507 0.3352 1.0461 (0.9675-1.1310)
2 0.0435 0.0506 0.8601 (0.6650-1.1126)
(SNP9, SNP10) 00 0.5863 0.6335 0.9255 (0.8841-0.9689)
01 0.0610 0.0240 2.5463 (1.9135-3.3885)
10 0.0055 0.0107 0.5166 (0.2610-1.0224)
11 0.3092 0.2919 1.0590 (0.9717-1.1540)
12 0.0020 0.0020 1.0018 (0.2831-3.5456)
21 0.0010 0.0010 1.0018 (0.1676-5.9902)
22 0.0335 0.0370 0.9071 (0.6734-1.2218)
(SNP10, SNP11) 00 0.5463 0.5922 0.9224 (0.8776-0.9695)
01 0.0455 0.0506 0.8997 (0.6982-1.1593)
02 0.0015 0.0013 1.1271 (0.2525-5.0304)
10 0.0595 0.0220 2.7095 (2.0164-3.6408)
11 0.3032 0.2823 1.0739 (0.9839-1.1722)
12 0.0085 0.0126 0.6723 (0.3805-1.1877)
21 0.0020 0.0023 0.8587 (0.2517-2.9296)
22 0.0335 0.0366 0.9153 (0.6791-1.2336)
The explanation for how the relative risks are obtained and displayed is the same as that given in Table 3. The major/minor alleles for rs6487236, 
rs1871142 and rs10770836 are A/G, G/A and G/A, respectively. The allelic information is extracted from the original T2D data. SNP9 = rs6487236, 
SNP10 = rs1871142 and SNP11 = rs10770836.BMC Bioinformatics 2009, 10:294 http://www.biomedcentral.com/1471-2105/10/294
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culated from the contingency table of alleles or genotypes
with disease status. On the other hand, a χ2 statistic for the
deviation from HWE of each SNP in the case samples indi-
cates the level of association. A large deviation from the
equilibrium usually signifies strong association between a
SNP and the disease. However, an excessively large devia-
tion may be the result of genotyping errors. nd SNPs with
largest test statistics for the deviation from HWE are hence
excluded from the consideration.
The test statistics for the allelic association and deviation
from HWE are multiplied together to form a single S sta-
tistic for each remaining SNP. SNPs are then ranked
according to their S statistics. A preset number of SNPs
with highest ranks are considered for association. The first
candidate SNP set contains only the SNP with the highest
rank (the highest S statistic). The p-value for this first set is
determined from a permutation simulation where the
case and control labels are randomly permuted while the
numbers of case and control samples remain unchanged.
In each permutation replicate, a new genotype contin-
gency table is constructed and a new S statistic is subse-
quently obtained. The p-value is given by the fraction of
permutation replicates with an S statistic greater than or
equal to the S statistic from the original data. The second
candidate SNP set consists of the first two SNPs in the rank
list. The test statistic for this SNP set is the sum of S statis-
tics from both SNPs. The p-value for the second candidate
SNP set is also obtained through the permutation simula-
tion. By progressively adding the remaining SNP with the
highest rank to the previously considered candidate set
and performing the permutation simulation, p-values for
all candidate SNP sets are estimated. The sizes of candi-
date SNP sets have the range of one to the preset number.
Among all candidate sets, the SNP set that best describes
genetic association has the lowest p-value.
Since multiple hypotheses are postulated during the con-
struction of candidate SNP sets, the global p-value for the
selected candidate set must be evaluated. This is achieved
through a permutation simulation in which the current
raw p-value for the chosen candidate set is now used as the
test statistic. The existing permutation replicates, created
for the early estimation of the raw p-value, can be reused
and a nested permutation simulation is hence avoided. In
this study, the maximum allowable size of the candidate
Table 10: Haplotype relative risk evaluated from genotype distribution of SNPs in GYS2.
Frequency
SNP Allele and Haplotype Case Control Relative Risk 95% CI
SNP9 0 0.8057 0.8098 0.9949 (0.9757-1.0146)
1 0.1943 0.1902 1.0216 (0.9412-1.1087)
SNP10 0 0.7789 0.8026 0.9705 (0.9505-0.9908)
1 0.2211 0.1974 1.1201 (1.0367-1.2102)
SNP11 0 0.7811 0.7818 0.9992 (0.9782-1.0205)
1 0.2189 0.2182 1.0030 (0.9299-1.0818)
(SNP9, SNP10) 00 0.7740 0.7967 0.9715 (0.9512-0.9922)
01 0.0317 0.0131 2.4258 (1.8357-3.2056)
10 0.0049 0.0059 0.8330 (0.4807-1.4433)
11 0.1894 0.1843 1.0276 (0.9455-1.1169)
(SNP10, SNP11) 00 0.7494 0.7692 0.9742 (0.9524-0.9965)
01 0.0295 0.0334 0.8843 (0.7069-1.1061)
10 0.0318 0.0126 2.5275 (1.9064-3.3511)
11 0.1894 0.1848 1.0244 (0.9426-1.1134)
The explanation for how the relative risks are obtained and displayed is the same as that given in Table 4. The allelic information for each SNP is 
given in Table 9. SNP9 = rs6487236, SNP10 = rs1871142 and SNP11 = rs10770836.
Table 11: Prediction accuracy of the best MDR model constructed from the 2LOmb output.
Description Value
SNP and Gene rs2269241 (PGM1), rs3790857 (PGM1), rs1893551 (PARK2), rs6924502 (PARK2), rs1871142 (GYS2), 
rs10770836 (GYS2)
Classification (Training) Accuracy 0.5709
Prediction Accuracy 0.5402
Cross-Validation Consistency (CVC) 9/10
The model contains six SNPs from PGM1, PARK2 and GYS2. A permutation test with 1,000 randomised replicates of case-control data for this 
model reveals that the empirical p-value for the null hypothesis of no association is p < 0.001.BMC Bioinformatics 2009, 10:294 http://www.biomedcentral.com/1471-2105/10/294
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SNP set is the total number of available SNPs while the
number of permutation replicates for p-value evaluation is
set to 10,000. The allelic association statistic employed in
the study is the χ2 statistic that is obtained through the
contingency table of genotypes with disease status. A PAS-
CAL program for the set association approach can be
obtained from the website for S statistic in gene mapping
[84].
Correlation-based feature selection technique
A correlation-based feature selection (CFS) technique [14]
is an attribute (SNP) subset evaluation heuristic that con-
siders both the usefulness of individual features (SNPs) in
the (case-control) classification task and the level of inter-
correlation among features. Each attribute subset is
assigned a score given by
where MeritF is the heuristic merit of an nc-attribute subset
F,  cf is the average feature-class correlation and  ff is the
average feature-feature inter-correlation. An attribute sub-
set receives a high merit score if it contains features that
are highly correlated with the class and at the same time
have low inter-correlation among one another. An appli-
cation of a best-first search for the best subset identifica-
tion is carried out to avoid searching through all possible
attribute subsets. CFS has been integrated into a Weka
package [85,86].
Tuned ReliefF
A tuned ReliefF (TuRF) algorithm is a ranking algorithm
for identifying genetic markers which are important in
case-control classification [16]. TuRF is built on a ReliefF
engine [15]. ReliefF randomly picks a sample from the
(case-control) data and identifies its nk nearest neighbours
from the same class and another nk nearest neighbours
from the opposite class. The attribute values--the geno-
types in this application--of the neighbour samples are
compared to that of the randomly picked sample and are
subsequently used to update the relevance score for each
attribute (genetic marker). This process is repeated for a
specified number of samples, which is limited by the total
sample size. The rationale of ReliefF is that an attribute
which is important for the classification should have dif-
ferent values for samples from different classes and have
the same value for samples from the same class. The rele-
vance score of an attribute have a range from -1 (not rele-
vant) to +1 (highly relevant). TuRF exploits the capability
of ReliefF by repeatedly executing ReliefF and removing a
portion of worst attributes at the end of each execution.
This leads to the reevaluation of remaining attributes and,
hence, reduces the effects of attribute noise on the
attribute screening. In this study, the number of repeti-
tions for random sample picking in the ReliefF part is
equal to the total number of case-control samples while
the neighbourhood size (nk) for the relevance score calcu-
lation is set to ten. Furthermore, the worst 1% of SNPs is
removed at the end of each ReliefF iteration (TuRF 1%).
TuRF has been integrated into the current distribution of
multifactor dimensionality reduction (MDR) software.
Merit
ncrcf
nc nc nc rff
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+− ()
,
1
(12)
r r
Table 12: Summary of prediction accuracy by MDR from early genetic association studies of T2D in a Korean population, a Han 
Chinese population from Taiwan, a female population from the US, and that from an early genetic association study of metabolic 
syndrome in an Italian population from the Centre East Coast Italy.
Reference Population Gene Prediction Accuracy CVC Permutation p-value
Cho et al. [43] Korean PPARG, UCP2 0.7957 9/10 0.01
Hsieh et al. [44] Han Chinese RXRG, EGFR 0.6270 11/12 N/A
Qi et al. [45] US KCNJ11, HNF4A 0.5420 10/10 0.010
Fiorito et al. [47] Italian PPARG, DIO2 0.6170 10/10 0.005
A permutation test with 1,000 randomised replicates is performed to obtain the empirical p-value for the null hypothesis of no association in the 
studies conducted in the US and Italian populations. In contrast, a permutation test with 100 randomised replicates is performed to obtain the 
empirical p-value in the study conducted in the Korean population.
Table 13: Penetrances for a two-locus interaction model.
Penetrance of Genotype
Genotype BB Bb bb Marginal Penetrance
AA f00 f01 f02 MA0
Aa f10 f11 f12 MA1
aa f20 f21 f22 MA2
Marginal Penetrance MB0 MB1 MB2 K
fij is the disease penetrance of genotype ij. MAi and MBj are the marginal penetrances for genotype i at locus A and genotype j at locus B, respectively. 
MAi = MBj = K, ∀i, j ∈ {0, 1, 2} in a pure epistasis model.BMC Bioinformatics 2009, 10:294 http://www.biomedcentral.com/1471-2105/10/294
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Multifactor dimensionality reduction
A multifactor dimensionality reduction (MDR) method is
a wrapper-based technique that is capable of identifying
the best genetic marker combination among possible
markers for the separation between case and control sam-
ples [19]. Similar to other wrapper-based methods, an nf -
fold cross-validation technique provides a means to deter-
mine the prediction accuracy of the candidate marker
model. Basically, the combined case and control samples
are randomly divided into nf folds where nf - 1 folds of
samples are used to construct a decision table while the
remaining fold of samples is used to identify the predic-
tion capability of the constructed decision table. The deci-
sion table construction and testing procedure is repeated
nf times. Hence, the samples in each fold are always used
both to construct and to test the decision table. The
number of cells in a decision table is given by   where
nc is the number of candidate markers selected from pos-
sible markers and G is the number of possible genotypes
according to the marker. For a SNP, which is a bi-allelic
marker, G is equal to three. During the decision table con-
struction, each cell in the table is filled with case and con-
trol samples that have their genotype corresponds to the
cell label. The ratio between numbers of case and control
samples provides the decision for each cell whether the
corresponding genotype is a protective or disease-predis-
posing genotype. An example of decision table construc-
tion is illustrated in Figure 13.
The prediction accuracy of the decision table is subse-
quently evaluated by counting the numbers of case and
control samples in the testing fold that their disease status
can correctly be identified using the constructed decision
rules. The process of decision table construction and eval-
uation must be cycled through all or some of possible
 - 1 combinations where nm is the total number of
available markers in the study. The best genetic marker
combination is determined from two criteria: prediction
accuracy and cross-validation consistency. Each time that
a testing fold is used for the prediction accuracy determi-
nation, the accuracy of the interesting marker combina-
tion model is compared with that from other models that
also contain the same number of markers. The model that
consistently ranks the first in comparison to other choices
with the same number of markers has high cross-valida-
tion consistency. Prediction accuracy is the main criterion
for decision making while cross-validation consistency is
only used as an auxiliary measure. Cross-validation con-
sistency generally confirms that the high rank model can
consistently be identified regardless of how the samples
are divided for cross-validation. In a situation where two
or more models with different number of markers are
equally good in terms of prediction accuracy and cross-
validation consistency, the most parsimonious model--
the combination with the least number of markers--is
chosen as the best model.
After the best model has been selected, a permutation test
is used to assess the probability of obtaining prediction
accuracy that is at least as large as or larger than that
observed in the original data from randomised data. This
G
nc
2
nm
Table 14: Two-locus penetrances that lead to the maximum 
heritability   (K) = 2K/(1 - K) for K ∈ (0, 1/4].
Penetrance of Genotype
Genotype BB Bb bb
AA 00 4 K
Aa 02 K 0
aa 4K 00
All allele frequencies are equal (pA = pB = 0.5).
hmax
2
Table 15: Three-locus penetrances that lead to the maximum 
heritability   (K) = 9K/(1 - K) for K ∈ (0, 1/16].
Penetrance of Genotype
Genotype CC Cc cc
BB Bb bb BB Bb bb BB Bb bb
AA 00 1 6 K 000000
Aa 000 0 4 K 000 0
aa 000 000 1 6 K 00
All allele frequencies are equal (pA = pB = pC = 0.5).
hmax
2
Table 16: Four-locus penetrances that lead to the maximum 
heritability   (K) = 35K/(1 - K) for K ∈ (0, 1/64].
Penetrance of Genotype
Genotype CC Cc cc
DD Dd dd DD Dd dd DD Dd Dd
BB 00000 0000
AA Bb 00000 0000
bb 00 6 4 K 00 0000
BB 00000 0000
Aa Bb 0000 8 K 0000
bb 00000 0000
BB 00000 0 6 4 K 00
aa Bb 00000 0000
bb 00000 0000
All allele frequencies are equal (pA = pB = pC = pD = 0.5).
hmax
2BMC Bioinformatics 2009, 10:294 http://www.biomedcentral.com/1471-2105/10/294
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represents the probability that the null hypothesis of no
association is true. Each permutation replicate is con-
structed by randomly assigning the case/control status to
each sample with the numbers of case and control sam-
ples remaining fixed. MDR analysis is subsequently car-
ried out to obtain the prediction accuracy of each
permutation replicate. The empirical p-value is denoted by
the fraction of permutation replicates with the prediction
accuracy greater than or equal to the prediction accuracy
obtained from the original data. MDR software, which
incorporates many additional features including interac-
tion visualisation via dendrograms and genetic marker
screening via a χ2 test, an odds ratio test, ReliefF and TuRF,
is available from its homepage [87].
JLIN
JLIN or a Java LINkage disequilibrium plotter is a compu-
ter program for visualisation of linkage disequilibrium
analysis [63]. The program is capable of displaying many
statistical measures including D' [64] and r2 [65]. The pro-
gram is publicly available from the Centre for Genetic Epi-
demiology and Biostatistics, University of Western
Australia [88].
Interaction dendrogram
An interaction dendrogram is a graphical tool for the vis-
ualisation of relationships among attributes (SNPs)
[68,69]. The interaction dendrogram is constructed via
hierarchical clustering analysis and is embedded into
MDR software [87]. The dendrogram illustrates the
entropy-based interaction between attributes by display-
ing interacting or related attributes closely together as
adjacent leaves in a tree. At the same time, independent
attributes are placed far apart from one another. In addi-
tion, the conclusion regarding whether the interaction
between attributes is synergistic or redundancy is present
can be deduced.
Availability and requirements
The 2LOmb program for Windows platforms and exam-
ples of simulated data are available at http://
code.google.com/p/nachol/w/list.
List of abbreviations
2LOmb: omnibus permutation test on ensembles of two-
locus analyses; ALT: alanine transaminase; ANOVA: anal-
ysis of variance; AST: aspartate transaminase; CFS: correla-
tion-based feature selection; CI: confidence interval; CVC:
cross-validation consistency; DIO2: deiodinase, iodothy-
ronine, type II; E2LA: exhaustive two-locus analysis;
EGFR: epidermal growth factor receptor (erythroblastic
leukemia viral (v-erb-b) oncogene homolog, avian); FAM-
HAP: software for single-marker analysis and joint analy-
sis of unphased genotype data from tightly linked markers
(haplotype analysis); FUSION: Finland-United States
Investigation of NIDDM Genetics; genomeSIM: simula-
tion package for generating case-control samples in large-
An MDR decision table that is constructed using a balanced  case-control data set with the sample size of 800 Figure 13
An MDR decision table that is constructed using a 
balanced case-control data set with the sample size 
of 800. The genotype of each sample is determined from 
two SNPs. The table consists of nine cells where each cell 
represents a unique genotype. The left (black) bar in each cell 
represents the number of case samples while the right 
(white) bar represents the number of control samples. The 
cells with genotypes AABB, AABb, AAbb, AaBB and aaBB are 
labelled as protective genotypes while the cells with geno-
types AaBb, Aabb, aaBb and aabb are labelled as disease-pre-
disposing genotypes.
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Table 17: Disease prevalence that gives the target maximum heritability of 0.01, 0.025 and 0.05 for two-, three- and four-locus 
interaction models.
Prevalence (K)
Model
 (K) = 0.01  (K) = 0.025  (K) = 0.05
Two-locus 0.004975 0.012346 0.024390
Three-locus 0.001110 0.002770 0.005525
Four-locus 0.000286 0.000714 0.001427
hmax
2 hmax
2 hmax
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scale and genome-wide association studies; GYS2: glyco-
gen synthase 2 (liver); HNF4A: hepatocyte nuclear factor
4, alpha; HuGENet: Human Genome Epidemiology Net-
work; HWE: Hardy-Weinberg equilibrium; JLIN: Java
LINkage disequilibrium plotter; KCNJ11: potassium
inwardly-rectifying channel, subfamily J, member 11; LD:
linkage disequilibrium; LIM domains: protein structural
domains that are named after their initial discovery in the
proteins Lin11, Isl-1 and Mec-3; LMX1A: LIM homeobox
transcription factor 1, alpha; MDR: multifactor dimen-
sionality reduction; NIDDM: noninsulin-dependent dia-
betes mellitus; PARK2: Parkinson disease (autosomal
recessive, juvenile) 2, parkin; PGM1: phosphogluco-
mutase 1; PPARG: peroxisome proliferator-activated
receptor gamma; RXRG: retinoid X receptor, gamma; SAA:
set association approach; SNP: single nucleotide polymor-
phism; T2D: type 2 diabetes mellitus; TuRF: tuned ReliefF;
UCP2: uncoupling protein 2 (mitochondrial, proton car-
rier); Weka: Waikato environment for knowledge analy-
sis; WTCCC: Wellcome Trust Case Control Consortium.
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